Literature DB >> 16503352

Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain.

Magdalena Sierra1, Alvaro Alonso, M Dolores Odero, M Belén Gonzalez, Idoia Lahortiga, José J Pérez, Juan L García, Norma C Gutiérrez, María J Calasanz, Jesús F San Miguel, Jesús M Hernández.   

Abstract

The incidence of chromosomal abnormalities in acute myeloid leukemia (AML) differs according to geographical regions in Spain. We analyse 1,271 consecutive patients diagnosed of AML between 1995 and 2002 in three different regions of Spain: northern, central and southern. There were 624 males (55%) and 505 females (45%). Age ranged between 1 month and 94 years with a median of 61 years. Abnormal karyotypes were observed in 64% of cases. Numerical abnormalities as sole cytogenetic changes were detected in 15% of patients, while structural aberrations were present in 28% of cases, and both abnormalities were found in 22% of patients. A significantly higher proportion of t(15;17) was observed in the south of Spain (21.6%) than in the central (17%) or northern regions (12.6%) (p=0.03). By contrast, patients from the south of Spain showed lower incidence of t(8;21) (0%, compared to 1.6% and 3.6% in central and northern areas, respectively, p=0.04). These differences were maintained in the age-adjusted analysis. Trisomy 8 showed similar incidence in southern and central areas, while the incidence in the northern area was lower (14% and 10%, respectively, p=0.04). Other chromosomal abnormalities, such as inv(16) or 11q23 rearrangements, were found at similar frequencies in the three regions.

Entities:  

Mesh:

Year:  2006        PMID: 16503352     DOI: 10.1016/j.leukres.2005.12.025

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  Epidemiology and treatment of acute promyelocytic leukemia in latin america.

Authors:  E M Rego; R H Jácomo
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-10-24       Impact factor: 2.576

2.  Cytogenetic and mutational analysis and outcome assessment of a cohort of 284 children with de novo acute myeloid leukemia reveal complex karyotype as an adverse risk factor for inferior survival.

Authors:  Xi Chen; Xingjuan Wang; Hu Dou; Zhenzhen Yang; Junqin Bi; Yi Huang; Ling Lu; Jie Yu; Liming Bao
Journal:  Mol Cytogenet       Date:  2021-05-19       Impact factor: 2.009

3.  Cytogenetic profile of adult acute myeloid leukemia in Egypt: a single-center experience.

Authors:  Mohamed G Elnaggar; Eman Mosad; Ahmed Makboul; Engy Adel Shafik
Journal:  Mol Cytogenet       Date:  2022-10-05       Impact factor: 1.904

4.  Allogeneic stem cell transplantation in acute myeloid leukemia.

Authors:  Natasha Ali; Salman Naseem Adil; Mohammad Usman Shaikh; Nehal Masood
Journal:  Hematol Rep       Date:  2012-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.